7.5% Growth in Indian Pharma Market in February, Boosted by Cardiac, GI, and Diabetes Drugs
Health Ministry seizes spurious cancer, diabetes drugs worth Rs 6.6 cr in Kolkata
S. Korean drugmaker Celltrion to buy back its shares for 4th time in 2024